Zimbabwe has turned down a major US healthcare agreement worth 367 million US dollars (£272m) spanning five years because of Washington's request for sensitive information.
The decision was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa felt the deal was "skewed".
A government spokesman has since clarified that the US was requesting biological samples for scientific study and commercial purposes while was not willing to guarantee the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for continued talks to find a deal suitable to all parties so the nation's critical HIV treatment initiative can proceed.
Broader Background
This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had administered assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and accountability.
According to statements, Sixteen nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our population if a future health crisis emerge."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were undermining structures already established via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with potential pandemics.
"This framework is intended to ensure that when a country provides its information, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future co-operation might be designed in a way that honours the independence and dignity of both nations."
Medical Community Reaction
Medical experts expressed it understood the official position, but urged that negotiations need to persist given that a large portion of the country's Aids initiatives were funded by international support.
"In cases where specific concerns exist, such as those involving information security or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," it added.
This impasse emphasises the complex debate between receiving much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.